End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index; 1 of the 9 sources its claims cite were checked for support.
Abstract
Despite a wealth of research regarding COVID-19, little evidence exists about cancer patients’ specific needs and experiences at end-of-life. This study retrospectively describes the care of 34 hospitalised cancer patients dying with COVID-19. The palliative care needs of patients were described. The main domains of end-of-life care service provision were evaluated including treatment of pain and other symptoms, communication and decision making at end-of-life and level of involvement of the palliative care team. Physical symptoms were managed with relatively low doses of end-of-life medications. High levels of patient and family anxiety, however, highlight the complexity of death from a stigmatised disease. Prompt acknowledgement of the vulnerability of advanced cancer patients with COVID-19 can facilitate proactive symptom management, anticipatory communication and enhance family support.
Overview
CoChat Summary
TL;DR
This retrospective single-center study describes end-of-life care for 34 hospitalized cancer patients who died with COVID-19 during the first two waves of the pandemic. It found that symptom management was generally low-dose and manageable, but patient and family anxiety, rapid deterioration, and communication challenges made the dying experience complex.
Key findings
- 34 patients were included: 29 non-ventilated PCR-positive deaths and 5 additional cases with strong clinical suspicion of COVID-19.
- Half of all patients had WHO performance status 3 at baseline, indicating substantial care needs.
- End-of-life medication use was relatively modest: median total opioid dose in the last 24 h was 30 mg oral morphine equivalent (range 5–180 mg) and median benzodiazepine dose was 10 mg (range 0–30 mg); 79% (n = 27) required a continuous subcutaneous infusion in the last 24 h of life.
- Palliative care was involved in most cases, but more often in wave 1 than wave 2 (89% [17/19] vs 73% [11/15]); all patients had DNACPR orders and treatment escalation plans in place at death.
- Patient and family anxiety were the most prevalent issues; 50% of identified family concerns (n = 20) related to the unexpected rapid deterioration from COVID-19.
Methods
- Retrospective service evaluation at a tertiary referral cancer centre; approved by the local Committee for Clinical Research (SE948).
- Included all non-ventilated inpatients aged >18 years who died with confirmed PCR COVID-19 or strong clinical suspicion of COVID-19 during 25 March 2020–1 May 2020 and 5 December 2020–1 March 2021.
- Data were extracted from medication charts and electronic records using a standardized proforma and analyzed with descriptive statistics in SPSS v27; IPOS scoring, documentation review, and thematic analysis of communication notes were used to assess symptoms, care planning, and family communication.
Limitations
- The paper explicitly states the study is limited by the small numbers and its retrospective nature.
- The authors note they did not have direct information on how patients and families perceived the end-of-life experience.
- Ventilated and sedated patients were excluded, so findings do not apply to that subgroup.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
1 Valid · 6 Not valid · 6 Not checked · 28 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, <25% of the patients included in these studies had cancer and there is little published data about cancer patients’ specific needs and experiences at end-of-life during the pandemic.”
§ End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19 > Introduction Since the outbreak of the pandemic severe acute respiratory syndrome-coronavirus-2 (COVID-19), there has been much research on the features and outcomes of this disease. Large multicentre studies have examined the implications of a cancer diagnosis and systemic anti-cancer therapy (SACT) on COVID-19 mortality and found no increased mortality in patients who had received SACT within 4 weeks of COVID-19 infection (1,2). Advanced disease, poor performance status, and comorbidities have been associated with higher mortality, as well as male gender, increased age, smoking, and cardiovascular disease (3). The pandemic is expected to have a protracted effect on cancer service provision, with an estimated 45,000 late cancer diagnoses in the UK after the first year (4,5). Work reviewing the experience of bereaved family members during the pandemic identified worsened psychological wellbeing in the context of social isolation, communication challenges and hospital visiting restrictions (6–8). Small studies conducted in the UK described the end-of-life symptoms of patients with COVID-19 (9,10). However, <25% of the patients included in these studies had cancer and there is little published data about cancer patients’ specific needs and experiences at end-of-life during the pandemic. As the pandemic enters its second year, with additional COVID-19 variants emerging, and as countries face new waves of infection, preparation and planning for end-of-life care provision for cancer patients remain a priority.
What the sources say
- Not checked yetcites [9]
- Partly supportedcites [10] sourceExperimental — accuracy not yet measured
Our copy supports the adjacent quantitative half of the citing sentence — Table 1 (Results) records 'Advanced/metastatic cancer 25' among the 101 referred inpatients, i.e. ~24.8% (<25%) — but it does not state a cancer-specific evidence gap. The paper's gap statements are general to all people with COVID-19: the Introduction says 'Data are lacking on the palliative care needs of people with COVID-19, including symptom burden and response to treatment', the Abstract 'hospital palliative care is an essential part of the COVID-19 response but data are lacking', and the Conclusion calls for urgent research on symptom prevalence/management and delivery in ICU and community settings. Nothing in our copy (searched: cancer-specific end-of-life needs, published data gaps, advanced/metastatic cancer subgroup) narrows the paucity of published data to cancer patients' specific needs and experiences at end-of-life, and no cancer subgroup analysis is reported, so that part of the claim is unsupported by this source. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The most frequently reported physical symptoms were weakness, poor mobility, poor appetite and shortness of breath.”
§ End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19 > Results > Overview
- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“More patients were referred to palliative care during wave 1 (89% (17/19) compared to 73% (11/15) in wave 2).”
§ End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19 > Results > Overview
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In total, 82% (n = 28) of patients had documentation that they were settled and comfortable at the time of death.”
§ End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19 > Results > Overview
plainn = 28- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In total, 76.5% (n = 26) of patients had a family member who visited the hospital in their final hours.”
§ End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19 > Results > Overview
plainn = 26- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
21 more claims
Create a free account to see all 41 claims and to verify the 8 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 9
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many of the participants irrespective of age, cancer type, or treatment regimen expressed unmet needs related to psychological or emotional domains of well-being [19–21, 24–28].”
From The unmet supportive care needs of people affected by cancer during the COVID-19 pandemic: an integrative review (2023) · cites this paper as [19]
Experimental — accuracy not yet measuredIn the citing paper
“Common needs reported included fatigue, weakness, and mobility issues affecting physical functioning and activities of daily living because of restrictions during the COVID-19 pandemic [19–23].”
From The unmet supportive care needs of people affected by cancer during the COVID-19 pandemic: an integrative review (2023) · cites this paper as [19]
Citations
Cites
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C.-Y., Desai, A., de Lima Lopes, G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31187-9 · Cited by 1,726 · cited 1×
“Large multicentre studies have examined the implications of a cancer diagnosis and systemic anti-cancer therapy (SACT) on COVID-19 mortality and found no increased mortality in patients who had received SACT within 4 weeks of COVID-19 infection (1,2).”
BackgroundLee, L. Y., Cazier, J.-B., Angelis, V., Arnold, R., Bisht, V., Campton, N. A., Chackathayil, J., Cheng, V. W., Curley, H. M., Fittall, M. W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31173-9 · Cited by 1,103 · cited 1×
“Large multicentre studies have examined the implications of a cancer diagnosis and systemic anti-cancer therapy (SACT) on COVID-19 mortality and found no increased mortality in patients who had received SACT within 4 weeks of COVID-19 infection (1,2).”
BackgroundThe impact of the COVID-19 pandemic on cancer care
Richards, M., Anderson, M., Carter, P., Ebert, B. L., & Mossialos, E. (2020) · Nature Cancer · doi:10.1038/s43018-020-0074-y · Cited by 587 · cited 1×
“The pandemic is expected to have a protracted effect on cancer service provision, with an estimated 45,000 late cancer diagnoses in the UK after the first year (4,5).”
BackgroundMurtagh, F. E., Ramsenthaler, C., Firth, A., Groeneveld, E. I., Lovell, N., Simon, S. T., Denzel, J., Guo, P., Bernhardt, F., Schildmann, E., et al. (2019) · Palliative Medicine · doi:10.1177/0269216319854264 · Cited by 413 · cited 2×
“• Identification of individual patients’ needs: The symptoms and palliative care needs of patients were described using the validated integrated palliative outcome scale (IPOS), which is routinely used in clinical care locally and nationally (11).”
BackgroundResultBereavement Support on the Frontline of COVID-19: Recommendations for Hospital Clinicians
Selman, L. E., Chao, D., Sowden, R., Marshall, S., Chamberlain, C., & Koffman, J. (2020) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.04.024 · Cited by 261 · cited 1×
“Research during the pandemic has highlighted the importance of effective communication and family support (20) and the emergence of novel technologies to overcome social distancing barriers (21).”
BackgroundLovell, N., Maddocks, M., Etkind, S. N., Taylor, K., Carey, I., Vora, V., Marsh, L., Higginson, I. J., Prentice, W., Edmonds, P., et al. (2020) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.04.015 · Cited by 221 · cited 1×
“Small studies conducted in the UK described the end-of-life symptoms of patients with COVID-19 (9,10).”
BackgroundPalliative Care Phase: Inter-rater reliability and acceptability in a national study
Masso, M., Allingham, S. F., Banfield, M., Johnson, C. E., Pidgeon, T., Yates, P., & Eagar, K. (2015) · Palliative Medicine · doi:10.1177/0269216314551814 · Cited by 172 · cited 1×
“The palliative phase of illness at first review was also included (13).”
BackgroundA qualitative study of bereaved relatives’ end of life experiences during the COVID-19 pandemic
Hanna, J. R., Rapa, E., Dalton, L. J., Hughes, R., McGlinchey, T., Bennett, K. M., Donnellan, W. J., Mason, S. R., & Mayland, C. R. (2021) · Palliative Medicine · doi:10.1177/02692163211004210 · Cited by 147 · cited 1×
“Family and carers play a key supportive role as patient advocates throughout the patient’s cancer journey (22).”
BackgroundOpportunities to improve COVID-19 provider communication resources: A systematic review
Wittenberg-Lyles, E. M., Goldsmith, J. V., Chen, C., Prince‐Paul, M., & Johnson, R. R. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2020.12.031 · Cited by 130 · cited 1×
“Research during the pandemic has highlighted the importance of effective communication and family support (20) and the emergence of novel technologies to overcome social distancing barriers (21).”
BackgroundSelman, L. E., Chamberlain, C., Sowden, R., Chao, D., Selman, D., Taubert, M., & Braude, P. (2021) · Palliative Medicine · doi:10.1177/02692163211017026 · Cited by 97
Research works printed but not linked: 4
- UK CR, 2021, Cancer News [Internet]
- Selman L, 2021, medRxiv, 34, 1249
- Partnership NPEoLC, 2021, Ambitions for palliative and end of life care: A national framework for local action 2021–2026
- Bradshaw A, 2020, medRxiv, 35, 1225
Cited by
Legge, H., Toohey, K., Kavanagh, P. S., & Paterson, C. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01275-z · Cited by 31
“Participants expressed feelings of isolation because they were not allowed to attend or support the patient during treatment or be present during discussions with the medical team due to COVID-19 restrictions [19, 23, 27].”
BackgroundInfluentialKazazian, K., Ng, D. W. J., & Swallow, C. J. (2022) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000606 · Cited by 10
Higginson, I. J., Hocaoğlu, M., Fraser, L., Maddocks, M. M., Sleeman, K. E., Oluyase, A. O., Chambers, R. L., Preston, N. J., Dunleavy, L., Bradshaw, A., et al. (2022) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2022.06.009 · Cited by 7
Legge, H., Toohey, K. L., Kavanagh, P. S., & Paterson, C. C. (2023) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2023.151508 · Cited by 2
Metadata
- Authors
- McFarlane, P., Halley, A., Kano, Y., Wade, N., Wilson, S., & Droney, J.
- Affiliations
- Royal Marsden NHS Foundation Trust (GB)
- Corresponding author
- McFarlane, Philippa
- Venue
- Journal of Patient Experience
- Publisher
- SAGE Publications
- Published
- 2022-01
- Volume
- 9
- Pages
- 23743735221074171-23743735221074171
- ISSN
- 2374-3735 (ISSN-L)
- 2374-3743
- PMC
- PMC8801342
- OpenAlex
- W4210567126
- Cited by
- 4
- References
- 23
- Citations by year
- 2023: 1 · 2022: 3
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Patient Experience (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- COVID-19 pandemic, cancer patients, end-of-life care, palliative care, symptom management, pain management, end-of-life decisions, family anxiety, stigma, hospitalized patients
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19. https://app.cochat.ai/papers/10.1177/23743735221074171
- The paper
- McFarlane, P., Halley, A., Kano, Y., Wade, N., Wilson, S., & Droney, J. (2022). End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19. Journal of Patient Experience. https://doi.org/10.1177/23743735221074171
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.